Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0016020 | membrane | 2 | 2 |
Related structures:
AlphaFold database: Q4Q9G3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.434 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.550 |
DEG_APCC_DBOX_1 | 139 | 147 | PF00400 | 0.505 |
DOC_CYCLIN_RxL_1 | 76 | 85 | PF00134 | 0.325 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.341 |
LIG_14-3-3_CanoR_1 | 133 | 139 | PF00244 | 0.483 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.479 |
LIG_BIR_III_2 | 158 | 162 | PF00653 | 0.481 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.440 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.420 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.546 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.518 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.350 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.391 |
LIG_LIR_Gen_1 | 39 | 46 | PF02991 | 0.347 |
LIG_LIR_Gen_1 | 85 | 95 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.334 |
LIG_Rb_pABgroove_1 | 81 | 89 | PF01858 | 0.335 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.437 |
LIG_TRAF2_1 | 148 | 151 | PF00917 | 0.553 |
LIG_TRAF2_1 | 6 | 9 | PF00917 | 0.306 |
LIG_UBA3_1 | 86 | 91 | PF00899 | 0.378 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.490 |
MOD_GlcNHglycan | 92 | 96 | PF01048 | 0.360 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.504 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.424 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.392 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.487 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.469 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.491 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.373 |
MOD_NEK2_2 | 82 | 87 | PF00069 | 0.457 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.478 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.494 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.473 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.504 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.440 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.418 |
MOD_SUMO_rev_2 | 6 | 11 | PF00179 | 0.441 |
TRG_DiLeu_BaEn_1 | 151 | 156 | PF01217 | 0.484 |
TRG_ER_diArg_1 | 139 | 141 | PF00400 | 0.432 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5J3 | Leptomonas seymouri | 72% | 100% |
A0A0S4IJA5 | Bodo saltans | 24% | 79% |
A0A1X0NST0 | Trypanosomatidae | 36% | 100% |
A0A3S7WZL3 | Leishmania donovani | 93% | 100% |
A0A422NVH2 | Trypanosoma rangeli | 39% | 100% |
A4I1W5 | Leishmania infantum | 92% | 100% |
C9ZS55 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AIS0 | Leishmania braziliensis | 81% | 100% |
E9AY10 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5DR87 | Trypanosoma cruzi | 39% | 100% |